Text Size

Retrospective Treatment Pattern Survey for the Patient With and Without History of Stroke (SAPIENCE)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00785057
First received: November 4, 2008
Last updated: December 2, 2010
Last verified: December 2010
History of Changes
  Purpose

This study will compare hypertension treatment pattern of stroke patients with non-stroke patients receiving medical care from outpatient clinics at neurology specialty centers in Korea. It will evaluate target BP achievement rate in patients with stroke compared to patients without stroke and investigate factors affecting BP target goal efficacy in these patients.


Condition
Hypertension

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: A Retrospective, Multi Centre, Non-interventional, Observational Study to Compare Treatment Pattern and Factors That Affect BP Control in Patients With and Without Stroke

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by AstraZeneca:

Primary Outcome Measures:
  • Blood pressure, History of stroke, Antihypertensive medication [ Time Frame: After collecting all Patient Record Form. ]

Secondary Outcome Measures:
  • Blood pressure, History of stroke, antihypertensive medication, Classification of stroke, Risk factors, Concomitant medication, etc. [ Time Frame: After collecting all Patient Record Form. ]

Estimated Enrollment: 1000
Study Start Date: November 2008
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
Hypertension patients with history of stroke
2
Hypertension patients without history of stroke

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Hypertension outpatients coming to the Neurology Department

Criteria

Inclusion Criteria:

  • Outpatients attending neurology specialty centers, either with or without history of stroke, receiving hypertension medication

Exclusion Criteria:

  • Secondary hypertension patients
  • Patients not receiving hypertension medication
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00785057

Locations
Korea, Republic of
Research Site
Goyang, Gyeonggi, Korea, Republic of
Research Site
Sungnam, Gyeonggi, Korea, Republic of
Research Site
Wonju, Kangwon, Korea, Republic of
Research Site
Busan, Korea, Republic of
Research Site
Deagu, Korea, Republic of
Research Site
Deajeon, Korea, Republic of
Research Site
Kwangju, Korea, Republic of
Research Site
Seoul, Korea, Republic of
Sponsors and Collaborators
AstraZeneca
Investigators
Study Director: Joonwoo Bahn Astrazenca Korea medical dept.
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00785057     History of Changes
Other Study ID Numbers: NIS-CKR-DUM-2008/4
Study First Received: November 4, 2008
Last Updated: December 2, 2010
Health Authority: Korea: Food and Drug Administration

Keywords provided by AstraZeneca:
Hypertension
Stroke
Neurology
 JNC7
2007 ESH-ESC guidelines
survey

Additional relevant MeSH terms:
Hypertension
Stroke
Vascular Diseases
Cardiovascular Diseases
 Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on May 22, 2013